NKCx Histopathological outcome* within 12 months after cervix cytology in 2016 |
431 Helsingborg |
Benign | CIN1 | CIN2 | CIN3 | AIS | Cancer | Other | PAD missing | Total | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cytology | Count | Pct | Count | Pct | Count | Pct | Count | Pct | Antal | Andel | Count | Pct | Count | Pct | Count | Pct | Count | Pct |
Benign sample | 400 | 2.2% | 17 | 0.1% | 4 | 0.0% | 10 | 0.1% | 1 | 0.0% | 1 | 0.0% | 33 | 0.2% | 18111 | 97.5% | 18577 | 100.0% |
ASCUS | 123 | 17.0% | 79 | 10.9% | 10 | 1.4% | 35 | 4.8% | . | . | . | . | 36 | 5.0% | 441 | 60.9% | 724 | 100.0% |
CIN1 | 89 | 22.3% | 82 | 20.6% | 22 | 5.5% | 45 | 11.3% | . | . | . | . | 27 | 6.8% | 134 | 33.6% | 399 | 100.0% |
Atypical glandular cells/AGC | 8 | 47.1% | 1 | 5.9% | . | . | . | . | 2 | 11.8% | 2 | 11.8% | . | . | 4 | 23.5% | 17 | 100.0% |
Unclear atypia | 3 | 15.0% | 3 | 15.0% | . | . | 5 | 25.0% | 2 | 10.0% | 1 | 5.0% | 2 | 10.0% | 4 | 20.0% | 20 | 100.0% |
ASC-H | 3 | 5.8% | 15 | 28.8% | 4 | 7.7% | 23 | 44.2% | . | . | 1 | 1.9% | 5 | 9.6% | 1 | 1.9% | 52 | 100.0% |
CIN2 | 8 | 4.5% | 18 | 10.1% | 54 | 30.3% | 90 | 50.6% | 1 | 0.6% | 1 | 0.6% | . | . | 6 | 3.4% | 178 | 100.0% |
CIN3 | 2 | 2.4% | . | . | 5 | 6.0% | 72 | 86.7% | . | . | 2 | 2.4% | . | . | 2 | 2.4% | 83 | 100.0% |
Adenocarcinoma | 1 | 12.5% | . | . | . | . | . | . | 1 | 12.5% | 2 | 25.0% | . | . | 4 | 50.0% | 8 | 100.0% |
Malignant tumor with unclear origin | . | . | . | . | . | . | . | . | . | . | 1 | 33.3% | 1 | 33.3% | 1 | 33.3% | 3 | 100.0% |
Squamous cell cancer | . | . | . | . | . | . | . | . | . | . | 6 | 85.7% | . | . | 1 | 14.3% | 7 | 100.0% |
Total | 637 | 3.2% | 215 | 1.1% | 99 | 0.5% | 280 | 1.4% | 7 | 0.0% | 17 | 0.1% | 104 | 0.5% | 18709 | 93.2% | 20068 | 100.0% |
NOTE: Histopathological outcome from T83x taken into account. |
This list includes only one diagnosis (the highest ranking) per person, applies to both Cyt and Pad. |
* Harmonization of PAD codes classification between analysis registry and process registry has been carried out. PAD Class 0 (non diagnostic, unreasonable diagnosis) is excluded, and next PAD counts instead. |
The classes 2a, b, c and 3a (suspected premalignant, pre-malignant UNS, HPV, suspected malignant) are grouped into 'Other'. |
Process Registry's Class 1 (benign), 2d (CIN1) and 3b (manifest cancer) have all been introduced without exception. Some codes that occur beyond the scope of the process registry has been added to the different categories. |
Snomed codes in the category Cancer: |
---|
M80203, M80703, M81403, M84413, M84416 |